fbpx Back to Top

Prostate Cancer Travel

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Program Open

Open - We are accepting applications for new and renewal patients. If your application for assistance is approved you can begin receiving funding immediately.

 

Prostate Cancer Travel Guidelines »

Assistance Amount

$2,100 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

 

Travel Assistance Information

Eligibility Criteria

  1. The patient must be getting treatment for prostate cancer.
  2. The patient must have Medicare health insurance that covers his qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. Patient must be required to travel greater than 20 miles (one way) to receive his prescribed treatment. Exceptions to distance requirements are made for patients living in large metropolitan cities.
  5. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  6. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)

 

list icon
See the list of medications covered in this program
View List  
  • Abiraterone Acetate (abiraterone acetate)
  • Bicalutamide (bicalutamide)
  • Carboplatin (carboplatin)
  • Casodex (bicalutamide)
  • Cisplatin (cisplatin)
  • Cortef (hydrocortisone)
  • Deltasone (prednisone)
  • Docefrez (docetaxel)
  • Docetaxel (docetaxel)
  • Eligard (leuprolide acetate)
  • Erleada (apalutamide)
  • Etopophos (etoposide phosphate)
  • Etoposide (etoposide)
  • Firmagon (degarelix acetate)
  • Flutamide (flutamide)
  • Hydrocortisone (hydrocortisone)
  • Jevtana (cabazitaxel)
  • Ketoconazole (ketoconazole)
  • Keytruda (pembrolizumab)
  • Leuprolide Acetate (leuprolide acetate)
  • Lupron Depot (leuprolide acetate)
  • Medrol (methylprednisolone)
  • Metastron (strontium-89 chloride)
  • Methylprednisolone (methylprednisolone)
  • Methylprednisolone Acetate (methylprednisolone acetate)
  • Methylprednisolone Acetate (methylprednisolone acetate in sodium chloride,iso-osmotic/pf)
  • Methylprednisolone Sodium Succ (methylprednisolone sodium succinate)
  • Mitoxantrone Hcl (mitoxantrone hcl)
  • Nilandron (nilutamide)
  • Nilutamide (nilutamide)
  • Prednisone (prednisone)
  • Prolia (denosumab)
  • Provenge (sipuleucel-t/lactated ringers solution)
  • Rayos (prednisone)
  • Taxotere (docetaxel)
  • Toposar (etoposide)
  • Trelstar (triptorelin pamoate)
  • Vantas (histrelin acetate)
  • Xgeva (denosumab)
  • Xofigo (radium-223 dichloride)
  • Xtandi (enzalutamide)
  • Yonsa (abiraterone acetate, submicronized)
  • Zoladex (goserelin acetate)
  • Zytiga (abiraterone acetate)

Diagnosis Codes:

ICD-10: C61, D07.5, D29.1

 

About the Disease:

Prostate cancer is a type of cancer that occurs in the prostate and can spread to the bones. It affects the exocine and skeletel systems.

 

Source: National Institutes of Health